InsiderClue
← All stocks

Crinetics Pharmaceuticals, Inc.

CRNX Net buying
CIK 0001658247 #989 in the set updated 19 Sep 2026
Bought (120 mo)
$62.80M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$95.80M
$8.89M on a plan · $42.83M straight out of an exercise
Sold at will
$44.09M
86 of 184 sales
Net
−$33.01M
+$18.71M against sales at will

By person

22 insiders · 216 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
PERCEPTIVE ADVISORS LLC entity
10% owner
$54.06M (5)
—
+$54.06M
5,321,032
5.02%
$212.84M
+1,630%
Struthers Richard Scott
President & CEO
$65.00K (2)
$23.19M (23) scheduled
−$23.12M
111,100
0.1047%
$4.44M
−91.6%
Vivo Capital VIII, LLC entity
10% owner
$6.58M (4)
$19.81M (34)
−$13.24M
298,625
0.2815%
$11.95M
—
5AM Ventures IV, L.P. entity
Former 10% holder
$1.96M (2)
$15.04M (6)
−$13.08M
94,489
0.0891%
$3.78M
—
Betz Stephen F.
Chief Scientific Officer
—
$8.75M (53) scheduled
−$8.75M
0
0.0000%
$0.00
−100.0%
Pizzuti Dana
Chief Med and Dev Officer
—
$7.11M (21) scheduled
−$7.11M
66,837
0.0630%
$2.67M
+1,584%
Knight Jeff E.
Chief Dev. & Operating Officer
—
$7.04M (11) scheduled
−$7.04M
105,289
0.0993%
$4.21M
+2,375%
Wilson Marc
CFO
—
$6.64M (9) scheduled
−$6.64M
111,092
0.1047%
$4.44M
+69.9%
Fust Matthew K
Director
—
$4.24M (12) scheduled
−$4.24M
0
0.0000%
$0.00
−100.0%
Hassard James
Chief Commercial Officer
—
$1.33M (2) scheduled
−$1.33M
29,259
0.0276%
$1.17M
—
Okey Stephanie
Director
—
$1.18M (4) scheduled
−$1.18M
0
0.0000%
$0.00
—
Madan Ajay
Chief Development Officer
—
$418.00K (2)
−$418.00K
176,995
0.1669%
$7.08M
+189.8%
Krasner Alan Seth
Chief Medical Officer
$34.00K (1)
$352.08K (2) scheduled
−$318.08K
43,210
0.0407%
$1.73M
+372.4%
Schilke Tobin
Chief Financial & Infra. Ofcr.
—
$266.30K (1) scheduled
−$266.30K
0
0.0000%
$0.00
−100.0%
Vivaldi Coelho Rogerio
Director
$110.30K (1)
$300.76K (3) scheduled
−$190.46K
0
0.0000%
$0.00
—
Kalofonos Isabel
Chief Commercial Officer
—
$137.50K (1) scheduled
−$137.50K
0
0.0000%
$0.00
−100.0%
WIERENGA WENDALL
Director
—
—
—
116,146
0.1095%
$4.65M
+55.9%
WIERENGA WENDELL
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Deardorf Caren
Director
—
—
—
0
0.0000%
$0.00
—
Nichols Weston
Director
—
—
—
0
0.0000%
$0.00
—
Bedrosian Camille L
Director
—
—
—
0
0.0000%
$0.00
—
Versant Venture Capital V, L.P. entity
10% owner
—
—
—
0
0.0000%
$0.00
—

Individual transactions

52
Insider
Date
Role
Action
Shares
Price
Amount
Knight Jeff E.
8 Apr 2026
Chief Dev. & Operating Officer
Sold after exercise
85,163
$40.10
$3.42M
Kalofonos Isabel
5 Jan 2026
Chief Commercial Officer
Sold after exercise
2,500
$55.00
$137.50K
Pizzuti Dana
1 Dec 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$45.02
$225.10K
Pizzuti Dana
3 Nov 2025
Chief Med and Dev Officer
Sold after exercise
100
$43.27
$4.33K
Pizzuti Dana
3 Nov 2025
Chief Med and Dev Officer
Sold after exercise
4,900
$42.65
$208.99K
Pizzuti Dana
1 Oct 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$41.81
$209.05K
Fust Matthew K
26 Sep 2025
Director
Sold after exercise
16,000
$44.75
$716.00K
Pizzuti Dana
2 Sep 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$32.10
$160.50K
Pizzuti Dana
22 Aug 2025
Chief Med and Dev Officer
Sold after exercise
30,000
$30.43
$912.90K
Betz Stephen F.
12 Jun 2025
Chief Scientific Officer
Sold after exercise
97,483
$32.23
$3.14M
Pizzuti Dana
3 Feb 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$39.07
$195.35K
Pizzuti Dana
3 Jan 2025
Chief Med and Dev Officer
Sold after exercise
15,000
$52.09
$781.35K
Pizzuti Dana
3 Oct 2024
Chief Med and Dev Officer
Sold after exercise
14,375
$54.63
$785.31K
Wilson Marc
26 Sep 2024
CFO
Sold after exercise
25,000
$51.11
$1.28M
Wilson Marc
25 Jul 2024
CFO
Sold after exercise
19,056
$53.88
$1.03M
Wilson Marc
15 Jul 2024
CFO
Sold after exercise
25,000
$55.00
$1.38M
Knight Jeff E.
15 Jul 2024
Chief Operating Officer
Sold after exercise
27,000
$55.00
$1.49M
Hassard James
5 Jul 2024
Chief Commercial Officer
Sold after exercise
15,000
$44.08
$661.20K
Pizzuti Dana
3 Jul 2024
Chief Med and Dev Officer
Sold after exercise
14,375
$44.87
$645.01K
Wilson Marc
28 Jun 2024
CFO
Sold after exercise
32,129
$43.61
$1.40M
Pizzuti Dana
24 Jun 2024
Chief Med and Dev Officer
Sold after exercise
9,500
$45.73
$434.44K
Hassard James
21 Jun 2024
Chief Commercial Officer
Sold after exercise
15,000
$44.66
$669.90K
Struthers Richard Scott
8 May 2024
President & CEO
Sold after exercise
107,448
$49.40
$5.31M
Pizzuti Dana
15 Apr 2024
Chief Med and Dev Officer
Sold after exercise
14,375
$44.47
$639.26K
Struthers Richard Scott
4 Apr 2024
President & CEO
Sold after exercise
40,951
$49.17
$2.01M
Okey Stephanie
28 Mar 2024
Director
Sold after exercise
17,500
$46.38
$811.65K
Knight Jeff E.
22 Mar 2024
Chief Operating Officer
Sold after exercise
2,359
$45.39
$107.08K
Knight Jeff E.
22 Mar 2024
Chief Operating Officer
Sold after exercise
30,000
$44.22
$1.33M
Fust Matthew K
20 Mar 2024
Director
Sold after exercise
17,500
$45.50
$796.25K
Fust Matthew K
20 Mar 2024
Director
Sold after exercise
17,500
$43.58
$762.65K
Fust Matthew K
20 Mar 2024
Director
Sold after exercise
12,500
$43.57
$544.63K
Fust Matthew K
20 Mar 2024
Director
Sold after exercise
12,500
$43.57
$544.63K
Pizzuti Dana
20 Mar 2024
Chief Med and Dev Officer
Sold after exercise
714
$43.69
$31.19K
Pizzuti Dana
20 Mar 2024
Chief Med and Dev Officer
Sold after exercise
10,000
$43.28
$432.80K
Pizzuti Dana
20 Mar 2024
Chief Med and Dev Officer
Sold after exercise
4,375
$45.89
$200.77K
Pizzuti Dana
3 Jan 2024
Chief Med and Dev Officer
Sold after exercise
14,375
$35.00
$503.13K
Wilson Marc
2 Jan 2024
CFO
Sold after exercise
10,000
$35.47
$354.70K
Pizzuti Dana
21 Dec 2023
Chief Med and Dev Officer
Sold after exercise
9,583
$34.57
$331.28K
Struthers Richard Scott
3 Nov 2023
President & CEO
Sold after exercise
199,082
$30.56
$6.08M
Struthers Richard Scott
2 Nov 2023
President & CEO
Sold after exercise
918
$29.95
$27.49K
Wilson Marc
1 Nov 2023
CFO
Sold after exercise
10,000
$28.75
$287.50K
Krasner Alan Seth
17 Oct 2023
Chief Medical Officer
Sold after exercise
7,000
$30.00
$210.00K
Wilson Marc
20 Jun 2023
CFO
Sold after exercise
20,000
$19.97
$399.40K
Wilson Marc
20 Jun 2023
CFO
Sold after exercise
10,922
$19.96
$218.00K
Fust Matthew K
13 Jul 2022
Director
Sold after exercise
5,700
$20.96
$119.45K
Krasner Alan Seth
19 Jan 2022
Chief Medical Officer
Sold after exercise
6,700
$21.21
$142.08K
Fust Matthew K
1 Nov 2021
Director
Sold after exercise
8,954
$25.50
$228.33K
Fust Matthew K
8 Sep 2021
Director
Sold after exercise
6,046
$25.50
$154.17K
Fust Matthew K
26 Jul 2021
Director
Sold after exercise
5,000
$19.59
$97.95K
Fust Matthew K
19 Jul 2021
Director
Sold after exercise
5,000
$19.50
$97.50K
Fust Matthew K
12 Jul 2021
Director
Sold after exercise
5,000
$20.71
$103.55K
Fust Matthew K
16 Dec 2019
Director
Sold after exercise
3,500
$22.50
$78.75K
Show all 216 transactions →

What was left out

Form 4 filings counted 272
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 20
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 52
Sales at will 86
Transactions with no price 0
Shares from compensation/vesting 22,218,718
Sales filed before the plan box existed 86
History held since 20 Jul 2018